Mark W. Hahn - 13 Oct 2025 Form 4 Insider Report for SOLENO THERAPEUTICS INC (SLNO)

Role
Director
Signature
/s/ Anish Bhatnagar, Attorney-in-Fact
Issuer symbol
SLNO
Transactions as of
13 Oct 2025
Transactions value $
$0
Form type
4
Filing time
14 Oct 2025, 16:23:45
Previous filing
08 Oct 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Hahn Mark W Director 100 MARINE PARKWAY, SUITE 400, REDWOOD CITY /s/ Anish Bhatnagar, Attorney-in-Fact 14 Oct 2025 0001408502

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SLNO Common Stock Award $0 +10K $0.00 10K 13 Oct 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Common Stock. One-third of the RSUs shall vest on October 13, 2026 and each one-year anniversary thereafter, subject to the Reporting Person continuing to be a Service Provider through each such date.